Results
| Patient No. . | Age/Sex . | Histology . | Stage . | Treatment . | Clinical Status . | SUV [max] . | MRFDG . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 42 . | End of CTx . | Follow-up . | Baseline . | Day 7 . | Day 42 . | Baseline . | Day 7 . | Day 42 . | |||||
| 1 | 77/F | Centroblastic | IV A | 6 × CHOP | PR | PD | Died | 15.6 | 3.3 | 2.5 | 9.30 | 1.58 | 0.54 |
| 2 | 30/F | Large B-cell | I AE | 6 × MGBG/CHOP | CR | CR | CR | 17.9 | 2.2 | 1.8 | 1.48 | 0.64 | 0.14 |
| 3 | 68/M | Diffuse large B-cell | II A | 6 × MGBG/CHOP | PR | CR | CR | 20.8 | 6.9 | 2.4 | 7.08 | 1.16 | 0.22 |
| 4 | 21/M | Burkitt's lymphoma | III B | 4 × CHOP/MGBG | PR | PD | Died | 10.5 | 3.6 | 3.2 | 5.69 | 1.50 | 1.37 |
| 5 | 73/F | T-cell rich B-cell | IV B | 6 × CHOP/MGBG | CR | CR | CR | 17.2 | 3.9 | 1.8 | 8.33 | 2.33 | 0.35 |
| 6 | 38/M | Large B-cell | IV | 4 × CHOP | PR | PD | PD | 13.3 | 9.3 | 4.1 | 8.26 | 3.96 | 1.80 |
| 7 | 31/M | Centroblastic large B-cell | II B | 6 × CHOEP | PR | CR | CR | 7.5 | 2.9 | 2.0 | 2.56 | 1.07 | 0.08 |
| 8 | 51/M | Centroblastic follicular B-cell | III B | 6 × CHOP-14 | PR | CR | CR | 11.5 | 4.6 | 2.3 | 8.48 | 1.11 | 0.01 |
| 9 | 58/F | Centroblastic large B-cell | III B | 6 × CHOEP | CR | CR | PD | 11.6 | 7.7 | 2.2 | 9.69 | 3.26 | 0.44 |
| 10 | 49/F | B-cell | III A | 6 × CHOP/MGBG | PR | CR | CR | 8.0 | 3.8 | 2.1 | 8.75 | 2.47 | 0.62 |
| 11 | 58/M | T-cell rich B-cell | III B | 6 × CHOP | PR | PD | Died | 12.9 | 6.9 | 4.4 | 4.98 | 3.18 | 1.60 |
| Patient No. . | Age/Sex . | Histology . | Stage . | Treatment . | Clinical Status . | SUV [max] . | MRFDG . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 42 . | End of CTx . | Follow-up . | Baseline . | Day 7 . | Day 42 . | Baseline . | Day 7 . | Day 42 . | |||||
| 1 | 77/F | Centroblastic | IV A | 6 × CHOP | PR | PD | Died | 15.6 | 3.3 | 2.5 | 9.30 | 1.58 | 0.54 |
| 2 | 30/F | Large B-cell | I AE | 6 × MGBG/CHOP | CR | CR | CR | 17.9 | 2.2 | 1.8 | 1.48 | 0.64 | 0.14 |
| 3 | 68/M | Diffuse large B-cell | II A | 6 × MGBG/CHOP | PR | CR | CR | 20.8 | 6.9 | 2.4 | 7.08 | 1.16 | 0.22 |
| 4 | 21/M | Burkitt's lymphoma | III B | 4 × CHOP/MGBG | PR | PD | Died | 10.5 | 3.6 | 3.2 | 5.69 | 1.50 | 1.37 |
| 5 | 73/F | T-cell rich B-cell | IV B | 6 × CHOP/MGBG | CR | CR | CR | 17.2 | 3.9 | 1.8 | 8.33 | 2.33 | 0.35 |
| 6 | 38/M | Large B-cell | IV | 4 × CHOP | PR | PD | PD | 13.3 | 9.3 | 4.1 | 8.26 | 3.96 | 1.80 |
| 7 | 31/M | Centroblastic large B-cell | II B | 6 × CHOEP | PR | CR | CR | 7.5 | 2.9 | 2.0 | 2.56 | 1.07 | 0.08 |
| 8 | 51/M | Centroblastic follicular B-cell | III B | 6 × CHOP-14 | PR | CR | CR | 11.5 | 4.6 | 2.3 | 8.48 | 1.11 | 0.01 |
| 9 | 58/F | Centroblastic large B-cell | III B | 6 × CHOEP | CR | CR | PD | 11.6 | 7.7 | 2.2 | 9.69 | 3.26 | 0.44 |
| 10 | 49/F | B-cell | III A | 6 × CHOP/MGBG | PR | CR | CR | 8.0 | 3.8 | 2.1 | 8.75 | 2.47 | 0.62 |
| 11 | 58/M | T-cell rich B-cell | III B | 6 × CHOP | PR | PD | Died | 12.9 | 6.9 | 4.4 | 4.98 | 3.18 | 1.60 |
Abbreviations: CR, complete response; PR, partial response; PD, progressive disease; CTx, chemotherapy; SUV, standardized uptake value of FDG in tumor; MRFDG, metabolic rate of FDG in tumor [mg/100 mL/min].